Personal information

Immune-Therapy, Gene-Therapy, Cancer, Functionl Genomics

Biography

Studied at Universities of Aberdeen and Sussex and completed a number of fellowships, including Beit, EMBO and MRC before joining King's College London in 1985. Was appointed the founding head of Department of Molecular Medicine in 1993 and awarded a Personal Chair in Molecular Medicine in1996. Elected to the Fellowship of the Royal College of Pathologists in 1997 and later that year to the Royal Society for the Encouragement of Arts, Manufacture & Commerce (FRSA) for his contributions to the development and public understanding of cancer gene therapy, and more recently to the Society of Biology (FSB). Having been a co-founder of the European Society for Cancer Gene Therapy, served as Secretary General of the International Society for Cell & Gene Therapy of Cancer (ISCGT) 2001-2006, and its President in 2007-2008. Published over 200 scientific papers and two edited books on the functional analysis of the genome and cancer gene therapy. Also head of a GMP facility since 2001 at King’s College Hospital London, producing Investigational Medicinal Products (IMP) for cell, gene therapy and regenerative medicine clinical studies. European Editor for Experimental Biology and Medicine. Current research focused on the functional analysis of the genome and immune therapy of cancer. The latter includes immune gene therapy of cancer and vaccination based induction of cellular immunity against chronically experienced antigens that are associated with malignant disease and persistent infections.

Activities

Employment (11)

Guy's and Saint Thomas' NHS Foundation Trust: London, London, GB

2014 to present | Qualified Person (Clinical Research Facility / GMP Labratories)
Employment
Source: Self-asserted source
Farzin Farzaneh

Great Ormond Street Hospital For Children NHS Trust: London, London, GB

2010 to present | Honorary Consultant, Qualified Person (Institute of Child Health )
Employment
Source: Self-asserted source
Farzin Farzaneh

King's College London: London, London, GB

2004 to present | Chair in Molecular Medicine (Haematological Medicine)
Employment
Source: Self-asserted source
Farzin Farzaneh

King's College Hospital: London, London, GB

2004 to present | Honorary Consultant in Molecular Medicine (Haematological Medicine)
Employment
Source: Self-asserted source
Farzin Farzaneh

King's College London: London, London, GB

1993 to 2004 | Head of Department (Molecular Medicine)
Employment
Source: Self-asserted source
Farzin Farzaneh

King's College London: London, London, GB

1990 to 1993 | Director of the Unit (Molecular Medicine Unit)
Employment
Source: Self-asserted source
Farzin Farzaneh

King's College London: London, London, GB

1987 to 1993 | Senior Lecturer (Molecular Genetics Unit)
Employment
Source: Self-asserted source
Farzin Farzaneh

King's College London: London, London, GB

1985 to 1987 | New Blood Lecturer (Obstetrics and Gynaecology)
Employment
Source: Self-asserted source
Farzin Farzaneh

University of Sussex: Brighton, Sussex, GB

1983 to 1984 | MRC Postdoctorla Fellow (Cell and Molecular Biology)
Employment
Source: Self-asserted source
Farzin Farzaneh

University of Amsterdam Swammerdam Institute for Life Sciences: Amsterdam, North Holland, NL

1982 to 1983 | EMBO Postdoctoral Fellow (Molecular Biology)
Employment
Source: Self-asserted source
Farzin Farzaneh

University of Sussex School of Life Sciences: Brighton, Brighton and Hove, GB

1979 to 1982 | Beit Memorial Postdoctoral Fellow (Cell and Molecvular Biology)
Employment
Source: Self-asserted source
Farzin Farzaneh

Education and qualifications (3)

University of Sussex: Brighton, Brighton and Hove, GB

1977 to 1979 | D.Phil (Cell and Molecular Biology)
Education
Source: Self-asserted source
Farzin Farzaneh

University of Aberdeen: Aberdeen, Aberdeen, GB

1976 to 1977 | MSc (Biochemsity)
Education
Source: Self-asserted source
Farzin Farzaneh

University of Aberdeen: Aberdeen, Aberdeen, GB

1975 to 1976 | BSc (Developmental Biology)
Education
Source: Self-asserted source
Farzin Farzaneh

Funding (5)

Next generation CAR19 studies

2015-10 to 2019-09 | Grant
NIHR Health Services and Delivery Research (HS&DR) programme (London, United Kingdom, GB)
GRANT_NUMBER:

II-C3-0714-20005

Source: Self-asserted source
Farzin Farzaneh

Large-Scale Lentiviral vector production

2015-10 to 2018-09 | Grant
Biotechnology and Biological Sciences Research Council (London, United Kingdom, GB)
GRANT_NUMBER:

BB/N003853/1

Source: Self-asserted source
Farzin Farzaneh

Pre-emptive immune therapy to prevent relapse of myeloid malignancies.

2013 to 2017 | Award
Leukaemia and Lymphoma Research (London, GB)
GRANT_NUMBER:

13007

Source: Self-asserted source
Farzin Farzaneh

Translational Activation of multiple adjuvant pathways to improve AML vaccine efficacy.

2013 to 2016 | Award
Leukaemia and Lymphoma Soceity, USA (New York, US)
Source: Self-asserted source
Farzin Farzaneh

Immune dysregulation in bone marrow failure syndromes: implications for pathogenesis and clonal evolution.

2010 to 2014 | Grant
Leukaemia and Lymphoma Research (London, GB)
GRANT_NUMBER:

10024

Source: Self-asserted source
Farzin Farzaneh

Peer review (3 reviews for 2 publications/grants)

Review activity for Cancer gene therapy. (2)
Review activity for Cancer immunology and immunotherapy. (1)